Dark Daily Hosted by R. Michel and Sylvia Christensen - Clinical Laboratory News/Trends

Home | Archive | About | Join..

Congressman Pete Stark Speaks Out on UnitedHealth's Plan to Fine Physicians and Condo (Pod) Labs

Since he first won election to Congress back in 1972, Representative Pete Stark (D-California) has earned a reputation for straight talk. That trait was exhibited yesterday during a speech Rep. Stark delivered at the annual meeting of the American Clinical Laboratory Association (ACLA) which is taking place this week in Washington, DC. Your Dark Daily editor was in the audience and taking notes.

In healthcare, Pete Stark is probably best known as the author of several bills commonly called the "Stark Laws." These laws address physician self-referral actions that would trigger anti-kickback violations. But yesterday, from the ACLA podium, it was an expansive Rep. Stark—discussing a range of topics of direct interest to the clinical laboratory industry. In particular, he touched upon two subjects that relate to anti-kickback situations. You are likely to find both fascinating and useful.

One subject was his strong reaction to the news that UnitedHealth Group, Inc. (UNH:NYSE) would fine physicians who referred laboratory tests to laboratories not holding contracts with UnitedHealth. He called it “bad news.” “That turns the Stark Law on its head!” declared Rep. Stark. “What is the difference between paying some fee to a doctor when he refers business and fining a doctor who won’t refer to the source that is providing a discounted service?

“It concerns me,” continued Rep. Stark. “My sense is that the professional judgment ought to be based on the best judgment of facts [about the patient’s case]. It ought not to be based on financial concerns.” Rep. Stark did not speak further on this point, but his statements reflect concern about the precedent now being established by UnitedHealth with its recent willingness to fine doctors as a way to stop leakage to out-of-network laboratories.

The second topic of particular interest involved anatomic pathology laboratory condominiums, also known as condo labs or pod labs. Rep. Stark did not discuss them in detail. Instead, he simply stated that, “I wait for the OIG decision on pod [condo] labs.” In my view, that statement demonstrates that Rep. Stark is alert to ways in which condo/pod labs can circumvent physician self-referral rules. It is likely that he is watching for pronouncements by healthcare regulators about the pod/condo lab matter, and, if necessary, he will take further action to constrain aspects of condo/pod lab arrangements that are considered abusive.

Over the 60 minutes that Rep. Stark spoke, it was obvious that he was familiar and informed about major issues of importance to the clinical laboratory industry. He touched upon competitive bidding, condo/pod labs, and how Medicare budget constraints are likely to influence funding for lab testing services, to name a few. This is significant, because a legislator must be aware of lab industry concerns in order to then vote intelligently on bills that affect these issues. On that point, it was clear that lobbying and educational efforts by ACLA and other laboratory professionals have definitely raised Rep. Stark’s awareness and understanding of the clinical laboratory profession and its specific needs.


Topics

Archive of DARK Daily
The Dark Report
The Executive War College
Consumer-Directed Health Plans White Paper

Dark Daily Explained

About Sylvia Christensen
About Robert Michel


Related Topics: